Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PACS (PACS) EBITDA: 2022-2024

Historic EBITDA for PACS (PACS) over the last 3 years, with FY2024 value amounting to $123.1 million.

  • PACS's EBITDA rose 27567.06% to $86.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $237.7 million, marking a year-over-year increase of 16875.09%. This contributed to the annual value of $123.1 million for FY2024, which is 4076.54% down from last year.
  • As of FY2024, PACS's EBITDA stood at $123.1 million, which was down 4076.54% from $207.8 million recorded in FY2023.
  • PACS's 5-year EBITDA high stood at $229.4 million for FY2022, and its period low was $123.1 million during FY2024.
  • Over the past 3 years, PACS's median EBITDA value was $207.8 million (recorded in 2023), while the average stood at $186.7 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 941.23% in 2023, then tumbled by 4076.54% in 2024.
  • Annual analysis of 3 years shows PACS's EBITDA stood at $229.4 million in 2022, then fell by 9.41% to $207.8 million in 2023, then tumbled by 40.77% to $123.1 million in 2024.
  • Its EBITDA was $123.1 million in FY2024, compared to $207.8 million in FY2023 and $229.4 million in FY2022.